title: Autoimmune pancreatitis in the setting of Castleman disease.
authors: Shishir K
authors: SK
authors: Maithel
authors: Wande
authors: W
authors: Pratt
authors: Thomas
authors: T
authors: Kelleher
authors: David
authors: D
authors: Avigan
authors: Harvey
authors: H
authors: Goldman
authors: Walther
authors: W
authors: Pfeifer
authors: German A
authors: GA
authors: Pihan
authors: Charles M
authors: CM
authors: Vollmer
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D001327:Autoimmune Diseases / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D001707:Biopsy, Needle; D005871:Castleman Disease / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D008297:Male; D010195:Pancreatitis / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D011241:Prednisone / Q000627:therapeutic use; D000069283:Rituximab; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D005938:Glucocorticoids; D007155:Immunologic Factors; D000069283:Rituximab; D011241:Prednisone